PANCREAZE 21,000 UNT / 61,000 UNT / 37,000 UNT Delayed Release Oral Capsule
RxNorm 968929
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 968929 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PANCREAZE 21,000 UNT / 61,000 UNT / 37,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 61000 UNT / lipase 21000 UNT / protease 37000 UNT Delayed Release Oral Capsule [Pancreaze]
(Atom ID: 12361226)
SY
Synonym (SY):
Pancreaze (amylases 61,000 UNT / endopeptidases 37,000 UNT / lipase 21,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845971)
SY
Synonym (SY):
Pancreaze 20 (amylase 61,000 UNT / lipase 21,000 UNT / protease 37,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845970)
PSN